What is Biogen's rituxan — until second gazyva threshold date?

Biogen (BIIB) reported rituxan — until second gazyva threshold date of 37.5% in Q1 2026.

How has Biogen's rituxan — until second gazyva threshold date changed year-over-year?

Biogen's rituxan — until second gazyva threshold date decreased by 0.0% year-over-year, from 37.5% to 37.5%.

What is the long-term trend for Biogen's rituxan — until second gazyva threshold date?

Over 2 years (2023 to 2025), Biogen's rituxan — until second gazyva threshold date has grown at a 0.0% compound annual growth rate (CAGR), from 150.0% to 150.0%.

What does rituxan — until second gazyva threshold date mean?

The time frame or status of a profit-sharing agreement before a secondary product reaches a specific milestone.

Products & Services · Until Second GAZYVA Threshold Date

RITUXAN — Until Second GAZYVA Threshold Date

Biogen RITUXAN — Until Second GAZYVA Threshold Date remained flat by 0.0% to 37.5% in Q1 2026 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from 37.5% to 37.5%. Over 2 years (FY 2023 to FY 2025), RITUXAN — Until Second GAZYVA Threshold Date shows relatively stable performance with a 0.0% CAGR.

Analysis

StatementSegment

CategoryOther

SignalContext dependent

VolatilityStable

First reportedQ3 2017

Last reportedQ1 2026

How to read this metric

Approaching the threshold date signals an impending change in the economic terms of the collaboration.

Detailed definition

This metric tracks the operational or financial status of a product collaboration during the period preceding a specific...

Peer comparison

Similar to milestone-based contract triggers found in biotech and pharmaceutical licensing or co-development deals.

Metric ID: biib_segment_rituxan_until_second_gazyva_threshold_date

Historical Data

15 periods

	Q4 '21	Q4 '22	Q1 '23	Q2 '23	Q3 '23	Q4 '23	Q1 '24	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Value	37.5%	37.5%	37.5%	37.5%	37.5%	37.5%	37.5%	37.5%	37.5%	37.5%	37.5%	37.5%	37.5%	37.5%	37.5%
QoQ Change	—	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%
YoY Change	—	+0.0%	—	—	—	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%

Range37.5% – 37.5%

CAGR+0.0%

Avg YoY Growth+0.0%

Median YoY Growth+0.0%

Current Streak14+ quarters growth

Similar Metrics at Other Companies

Idexx LaboratoriesIDXX View metric

Johnson & JohnsonJNJ View metric

Natera, Inc.NTRA View metric

Regeneron PharmaceuticalsREGN View metric

Frequently Asked Questions

What is Biogen's rituxan — until second gazyva threshold date?: Biogen (BIIB) reported rituxan — until second gazyva threshold date of 37.5% in Q1 2026.
How has Biogen's rituxan — until second gazyva threshold date changed year-over-year?: Biogen's rituxan — until second gazyva threshold date decreased by 0.0% year-over-year, from 37.5% to 37.5%.
What is the long-term trend for Biogen's rituxan — until second gazyva threshold date?: Over 2 years (2023 to 2025), Biogen's rituxan — until second gazyva threshold date has grown at a 0.0% compound annual growth rate (CAGR), from 150.0% to 150.0%.
What does rituxan — until second gazyva threshold date mean?: The time frame or status of a profit-sharing agreement before a secondary product reaches a specific milestone.